Ferring Inc. Sustainability Profile
Ferring Inc., a global biopharmaceutical company headquartered in California, has been a leader in reproductive health, urology, and gastroenterology since its founding in 1950. With a strong presence in North America, Europe, and Asia, Ferring is dedicated to developing innovative therapies that address unmet medical needs. The company is renowned for its core products, including hormone therapies and treatments for fertility and growth disorders, which are distinguished by their patient-centric approach and commitment to scientific excellence. Ferring's notable achievements include pioneering advancements in reproductive medicine, solidifying its position as a trusted name in the industry. With a focus on research and development, Ferring continues to push the boundaries of biopharmaceutical innovation, making significant contributions to healthcare worldwide.
DitchCarbon Score
How does Ferring Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ferring Inc.'s score of 30 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ferring Inc.'s reported carbon emissions
Ferring Inc., headquartered in California, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Ferring Holding SA, which may influence its climate commitments and reporting practices. While Ferring Inc. has not outlined specific reduction targets or initiatives, it is important to note that its parent company, Ferring Holding SA, may have established climate commitments that could cascade down to Ferring Inc. However, no specific details regarding these initiatives or targets have been provided. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints. Ferring Inc. is expected to align with industry standards and practices, potentially adopting science-based targets in the future. As the company develops its climate strategy, stakeholders will be looking for clear commitments and measurable outcomes in carbon emissions reduction.
How Carbon Intensive is Ferring Inc.'s Industry?
How Carbon Intensive is Ferring Inc.'s Location?
Ferring Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ferring Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
